KCNN4 and S100A14 act as predictors of recurrence in optimally debulked patients with serous ovarian cancer.
Zhao H, Guo E, Hu T, Sun Q, Wu J, Lin X, Luo D, Sun C, Wang C, Zhou B, Li N, Xia M, Lu H, Meng L, Xu X, Hu J, Ma D, Chen G, Zhu T.
Zhao H, et al. Among authors: zhou b.
Oncotarget. 2016 Jul 12;7(28):43924-43938. doi: 10.18632/oncotarget.9721.
Oncotarget. 2016.
PMID: 27270322
Free PMC article.